Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Articles By This Author
Goldman Sachs slants research to help Democrats, top White House adviser says
New York CNN Business — Kevin Hassett, one of President Donald Trump’s top economic advisers, suggested that Goldman Sachs may be slanting its economic research
Starbucks Offers Steady Growth: Financial Adviser
Mick Heyman has a conservative, long-term focus and thinks investors should have bonds in their portfolios. Source link
Notable Friday Option Activity: CBL, ABBV, ISRG
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in CBL & Associates Properties Inc (Symbol: CBL),
Panama’s economic recovery strong, but growth to slow in 2023, IMF says By Reuters
© Reuters. FILE PHOTO: A man walks past the International Monetary Fund (IMF) logo at its headquarters in Washington, U.S., May 10, 2018. REUTERS/Yuri Gripas/File
A Bull Market Is Coming: 1 Excellent Growth Stock to Buy Now
It’s hard to predict the future with certainty, but it’s safe to make some assumptions about how things will unfold in the next five or
Chardan Capital Downgrades Ouster (OUST)
On March 24, 2023, Chardan Capital downgraded their outlook for Ouster (NYSE:OUST) from Buy to Neutral. Analyst Price Forecast Suggests 232.74% Upside As of March
Australian govt opens consultation on competition in provision of clearing and settlement services
The Australian government has released exposure draft legislation amending the Corporations Act 2001, the Competition and Consumer Act 2010 and the ASIC Act 2001 to
Equity and IPOs: Navigating New Financial Opportunities
Companies headed toward an IPO have a responsibility to educate employees on the potential impact of the IPO on their wealth. It’s also to their
Kohl’s Will Pay You to Shop at its Stores
Kohl’s is giving back this holiday season, but not how you may think Source link
Can This New Drug Boost Pfizer’s Stock?
Pfizer‘s (NYSE: PFE) nasal spray Zavzpret was given the green light by the Food and Drug Administration earlier this month to treat patients with acute